Insider Trading & Ownership - BREITMEYER JAMES B

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BREITMEYER JAMES B
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-04-13
Purchase
2023-04-17
06:00 am
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
150,000 $0.29286 $43,930 763,176
(Indirect
Direct)
View
2022-01-27
Purchase
2022-01-31
4:00 pm
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
25,000 $1.6832 $42,080 437,919
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-14
Option Award
2024-02-15
6:00 pm
N/A
2034-02-14
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
34,600 $0 34,600
(Direct)
View
2024-01-03
Tax Withholding
2024-01-05
4:00 pm
N/A
N/A
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
55,440 $0.4961 655,737
(Direct)
View
2023-10-02
Option Award
2023-10-04
5:00 pm
N/A
2029-09-12
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
2,601,140 $0 2,591,380
(Direct)
View
2023-07-03
Tax Withholding
2023-07-05
6:59 pm
N/A
N/A
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
51,999 $0.36 711,177
(Direct)
View
2023-02-21
Option Award
2023-02-24
4:00 pm
N/A
2033-02-21
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
757,196 $0 757,196
(Direct)
View
2023-01-03
Tax Withholding
2023-01-05
6:00 pm
N/A
N/A
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
29,118 $1.02 613,176
(Direct)
View
2022-07-28
Option Award
2022-08-01
6:18 pm
N/A
2032-07-28
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
340,625 $0 778,544
(Direct)
View
2022-06-21
Option Award
2022-06-23
4:30 pm
N/A
2032-06-20
OTONOMY INC. OTIC BREITMEYER JAMES B
Director
27,500 $0 27,500
(Direct)
View
2022-03-07
Equity Swap
2022-03-09
7:16 pm
N/A
N/A
ZOGENIX INC. ZGNX BREITMEYER JAMES B
Director
1,250 $0 0
(Direct)
View
2022-01-20
Option Award
2022-01-24
4:14 pm
N/A
2032-01-20
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
802,000 $0 802,000
(Direct)
View
2022-01-03
Option Award
2022-01-05
7:00 pm
N/A
N/A
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
135,350 $0 413,219
(Direct)
View
2021-06-22
Option Award
2021-06-24
5:00 pm
N/A
2031-06-21
OTONOMY INC. OTIC BREITMEYER JAMES B
Director
17,500 $0 17,500
(Direct)
View
2021-05-27
Option Award
2021-05-28
8:03 pm
N/A
2031-05-27
ZOGENIX INC. ZGNX BREITMEYER JAMES B
Director
22,000 $0 22,000
(Direct)
View
2021-03-18
Option Award
2021-03-22
4:00 pm
N/A
2028-11-14
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
63,295 $0 105,492
(Direct)
View
2021-01-27
Option Award
2021-02-23
8:12 pm
N/A
2031-01-27
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
9,000 $0 9,000
(Indirect)
View
2021-02-11
Option Award
2021-02-16
6:00 pm
N/A
2031-02-11
Oncternal Therapeutics Inc. ONCT BREITMEYER JAMES B
Chief Executive Officer
750,000 $0 750,000
(Direct)
View
2020-05-29
Option Award
2020-06-29
9:12 pm
N/A
2030-05-29
ZOGENIX INC. ZGNX BREITMEYER JAMES B
Director
13,000 $0 13,000
(Direct)
View
2020-06-23
Option Award
2020-06-25
5:07 pm
N/A
2030-06-22
OTONOMY INC. OTIC BREITMEYER JAMES B
Director
17,500 $0 17,500
(Direct)
View